Law Offices of Howard G. Smith announces that it is investigating
potential claims against the Board of Directors of QuadraMed Corp.
("QuadraMed" or the "Company") (NASDAQ: QDHC) arising from the Company's
announcement of its intent to be acquired by Francisco Partners.
On December 8, 2009, the companies announced that Francisco Partners
will acquire QuadraMed in an all-cash transaction valued at $126
million. According to the agreement, shareholders will receive $8.50 per
share for QDHC common stock and $13.7097 per share of Series A
Cumulative Mandatory Convertible Preferred Stock. The investigation is
focused on the potential unfairness of the price to QuadraMed
shareholders and the process by which the QuadraMed Board of Directors
considered and approved the transaction.
If you own shares of QuadraMed, if you have information or would like to
learn more about these claims, or if you wish to discuss these matters
or have any questions concerning this announcement or your rights or
interests with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite
112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll
Free at 888-638-4847, or visit www.howardsmithlaw.com.
You may also email my firm at [email protected].